RISPERIDONE TABLET, FILM-COATED

TEVA

Revision date : 2014-03-11

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

215-691-6/1344-28-1

Name of the chemical

aluminium oxide

Concentration

Proprietary

EC/CAS

8004-92-0

Name of the chemical

1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts (CI 47005) (35), (36)

Concentration

Proprietary

EC/CAS

9004-65-3

Name of the chemical

methylhydroxypropylcellulose

Concentration

Proprietary

EC/CAS

215-570-8/1332-37-2

Name of the chemical

iron oxide

Concentration

Proprietary

EC/CAS

232-674-9/9004-34-6

Name of the chemical

cellulose

Concentration

Proprietary

EC/CAS

500-038-2/25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

038-2

EC/CAS

232-679-6/9005-25-8

Name of the chemical

Starch

Concentration

Proprietary

EC/CAS

13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

236-675-

EC/CAS

200-559-2

Name of the chemical

Lactose C12H22O11

Concentration

Proprietary

EC/CAS

209-150-3

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

Proprietary

General Information

Revision date

2014-03-11

Product name

RISPERIDONE TABLET, FILM-COATED

Chemical name

For Active Ingredient

1.2.2. Uses advised against

Other than Relevant Use

Manufacturer Name

TEVA

Emergency telephone

1-800/424-9300, 01-703-527-3887

Icons in SDS

Company Information

company name

TEVA

e-mail address of the competent person responsible for the Safety Data Sheet

TevaSDSRequest@tevapharm.com

Section 2

SECTION 2: Hazards identification

Product definition

This product is supplied as odorless, round, dark yellow (0.25 mg), red-brown (0.5 mg), white to off-white (1 mg), orange (2 mg), yellow (3 mg) or green (4 mg) tablets. Health Hazards: In the workplace, exposure via inhalation and skin contact may cause irritation. Dusts from tablets can cause mechanical irritation to the eyes. Accidental ingestion may be harmful. In therapeutic use, the most common adverse effects reported include somnolence, increased appetite, fatigue, insomnia, sedation, parkinsonism, unpleasant sensations of inner restlessness, vomiting, cough, constipation, nasopharyngitis, drooling, runny nose, dry mouth, abdominal pain upper, dizziness, nausea, anxiety, headache, nasal congestion, inflammation of nasal mucous membranes, tremor, and rash. Therapeutic use may cause adverse effects on the metabolic, central nervous and cardiovascular systems, and can cause blood disorders, which can be severe or fatal. In susceptible persons, therapeutic use may cause a severe reaction (Neuroleptic Malignant Syndrome [NMS]) accompanied with fever and body rigidity, renal failure and other serious symptoms, which can also be fatal. In certain individuals, long-term use may cause a condition that causes involuntary movements and can be permanent. Severe anaphylactic reactions have been reported. Some human evidence indicates possible harm to fetus during pregnancy. Limited evidence of adverse effect on fertility, based on animal information. Breast-feeding during therapeutic use may harm to infants. These effects may be possible as a result of workplace exposure. See Section 11 (Toxicological Information) for information on other potential health hazards known from therapeutic use. Flammability Hazards: This product requires substantial pre-heating before ignition occurs. When involved in a fire, this product may decompose and produce irritating vapors and toxic compounds (including aluminum, carbon, iron, magnesium, titanium, silicon, sodium and nitrogen oxides and hydrogen fluoride). Reactivity Hazards This product is not reactive.

Environmental hazards

The active ingredient is toxic to aquatic organisms and can cause long term damage in an aquatic environment. Release to the environment may have adverse effect. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.